Skip to content

Drug interactions

Enzalutamide + Vemurafenib

Severity: Major

Enzalutamide and Vemurafenib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Enzalutamide is a strong CYP3A4 inducer and vemurafenib is partly cleared by CYP3A4. Concurrent use may lower vemurafenib exposure and reduce its antitumor effect.

What this interaction means in plain words

Enzalutamide and Vemurafenib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Enzalutamide belongs to Endocrine; Vemurafenib belongs to Oncology.

Evidence level: Moderate

Why it happens

Enzalutamide induces CYP3A4, increasing the metabolism of vemurafenib.

What to do

Avoid the combination where an alternative is available. If it cannot be avoided, monitor for loss of tumor response and consider a vemurafenib dose increase according to the labeling.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Enzalutamide and Vemurafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Enzalutamide with Vemurafenib?

MediHelp rates the interaction as major. Enzalutamide and Vemurafenib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Enzalutamide is a strong CYP3A4 inducer and vemurafenib is partly cleared by CYP3A4. Concurrent use may lower vemurafenib exposure and reduce its antitumor effect.

How serious is the interaction between Enzalutamide and Vemurafenib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where an alternative is available. If it cannot be avoided, monitor for loss of tumor response and consider a vemurafenib dose increase according to the labeling.

What other medicines interact with Enzalutamide?

MediHelp also lists interactions of Enzalutamide with, for example, Doravirine, Elbasvir / grazoprevir, Ensitrelvir. The full list is on the Enzalutamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in